European Archives - Page 1074 of 1230 - European Medical Journal

Smoking Cessation with Lung Cancer: Not Too Little, Never Too Late!

Smoking is the leading cause of lung cancer (LC) worldwide, however any continuing effects of smoking or cessation following a diagnosis are less well…

Thoracic Surgery and Transplantation

Major changes are bringing a new dimension to thoracic surgery and lung transplantation. This article reports the foremost recent advancements within the…

Therapeutic Effect of Whole Lung Lavage on Pneumoconiosis

Pneumoconiosis as an occupational disease is a serious threat to the health of workers. Patients with pneumoconiosis are mainly engaged in dust-related…

Non-Intubated Video-Assisted Thoracic Surgery from Multi to Uniport Approaches: Single-Centre Experience

The success and evolution of video-assisted thoracic surgery (VATS) renewed the interest for thoracoscopic operations in awake patients. Non-intubated…

Chronic Obstructive Pulmonary Disease and Arterial Stiffness

Comorbidities are common in chronic obstructive pulmonary disease (COPD). Cardiovascular comorbidity is a leading cause of morbidity and mortality in…

EMJ

AMPA Receptors ‘Wedged’ Closed by Epilepsy Drugs

EPILEPSY drugs designed to target glutamatergic AMPA receptors have been revealed to act as ‘wedges’, preventing dysregulated transmission of…

Treatment Outcome Data from the Prostate Cancer Registry Presented for the First Time at the 2016 European Society for Medical Oncology (ESMO) Congress

Copenhagen, Denmark, October 10, 2016 – Janssen-Cilag International NV today presented the first reported primary treatment outcome data from…

Introducing EMJ Cardiology 4.1

Welcome to EMJ Cardiology 4.1, the go-to place for emerging academic and clinical research in the sphere of cardiology. This edition offers a number of…

Review of the European Society of Cardiology Congress 2016

Rome is home to a plethora of art and culture and this year it was also home to the annual ESC Congress. Taking place over 5 days, this event included…

Interpreting Findings with Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation: Collective Views on Data from Seminal Studies to Present in Clinical Practice

Clinical trials show that non-vitamin K antagonist oral anticoagulants (NOACs) have good efficacy-safety profiles relative to warfarin across a broad…